The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease

Thomas Foltynie, Simon G.J. Lewis, Terry E. Goldberg, Andrew S. Blackwell, Bhaskar S. Kolachana, Daniel R. Weinberger, Trevor W. Robbins, Roger A. Barker

Research output: Contribution to journalArticlepeer-review

99 Scopus citations


Parkinson's disease (PD) patients show a range of cognitive deficits,which may relate to abnormalities in dopaminergic transmission in fronto-striatal circuitry. In this study, we have investigated the impact of brainderived neurotrophic factor (BDNF) val66met polymorphisms on performance of the Tower of London (TOL) test of planning by PD patients. This polymorphism significantly influences BDNF secretion in the CNS, and BDNF is known to influence dopaminergic neurons and cognitive processes. Patients with PD totalling 291 who had undergone detailed motor and cognitive assessments as part of a population-based study of PD were genotyped for the BDNF val 66met polymorphism. The impact of this polymorphism on cognitive ability was determined using multivariate analysis to adjust for possible confounding variables. Patients with low rates of BDNF secretion (met alleles) performed significantly better at the TOL task than those with high rates of secretion (val alleles). Furthermore, subgroup analyses revealed that the effect is most apparent in women and among patients with prior dopaminergic exposure. We speculate that BDNF may interact with dopaminergic transmission and dopamine receptor stimulation in the frontostriatal circuitry, with subsequent consequences on cognition in Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)833-838
Number of pages6
JournalJournal of neurology
Issue number7
StatePublished - Jul 2005
Externally publishedYes


  • BDNF
  • Cognition
  • Parkinson's disease
  • Planning

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease'. Together they form a unique fingerprint.

Cite this